Prakriya Hospitals
| Day | Time |
|---|---|
| Sunday | N/A |
| Monday | N/A |
| Tuesday | N/A |
| Wednesday | N/A |
| Thursday | N/A |
| Friday | N/A |
| Saturday | N/A |
Consultation Fee
₹850

Laparoscopic Surgeon
4.5




Social Profiles:
Cancer Screening (Preventive)
Urinary Incontinence (Ui) Treatment
Robotic Surgery
D&C (Dilation and Curettage)
Breast Cancer Management
Lung Cancer Treatment
Gastric Balloon
Gynecological Cancer Treatment
Colonoscopy
Cancer Surgery
Mastectomy
Gastric Plication
Head and Neck Tumor / Cancer Surgery
Laparoscopic Adjustable Gastric Band
Endoscopic Surgery
Mini Port Surgeries
Dr. Pavan T Sugoor is a Laparoscopic Surgeon and Surgical Oncologist in Bangalore. He has 15 years of experience, with 14 years as a specialist. Dr. Sugoor completed his MBBS from Sri Siddhartha Medical College & Research in 2005, MS - General Surgery from MS Ramaiah Medical College in 2009, and MCh - Surgical Oncology from Tata Memorial Hospital in 2016.
Dr. Sugoor offers various services like Cancer Screening, Urinary Incontinence Treatment, Robotic Surgery, D&C, Breast Cancer Management, Lung Cancer Treatment, and more. He helps patients with different types of cancer and surgical procedures.
Dr. Sugoor is known for his excellent communication skills with patients. He listens carefully to their concerns and explains medical information in a simple way. Patients trust him because he is caring and supportive throughout their treatment journey.
To stay updated with the latest medical knowledge, Dr. Sugoor regularly attends conferences, reads research papers, and collaborates with other medical professionals. This helps him provide the best care based on the most recent advancements in the field.
Dr. Sugoor works well with his colleagues and values teamwork. He collaborates with other medical professionals to ensure comprehensive care for his patients. His positive relationships with colleagues contribute to a better healthcare experience for everyone involved.
Dr. Sugoor's work has had a positive impact on many patients' lives. His surgical expertise and compassionate approach have helped patients overcome cancer and other health challenges. Many patients have shared their gratitude for his dedication and skill in improving their health and well-being.
MBBS - Sri Siddhartha Medical College & Research, 2005
MS - General Surgery - MS Ramaiah Medical College and Teaching Hospital, Bangalore, 2009
MCh - Surgical Oncology - Tata Memorial Hospital, Mumbai, 2016
70955 Karnataka Medical Council, 2005
Issued by: Taongji University: Shanghai Pulmonary Hospital, Shanghai
Year: 2025
Fellowship in Uniportal VATS
Issued by: National Cancer Centre and Cancer Institute Ariake, Tokyo, Japan
Year: 2023
Fellowhip Robotic and Laparoscopy, Esophageal and Gastric Cancer Surgery
Description:Background The appropriate extent of gastric resection for patients with proximal third gastric cancer is controversial. This study addresses whether the choice of surgical strategy (proximal gastrectomy [PG] versus total gastrectomy [TG]) influences the outcomes for proximal third gastric adenocarcinoma. Materials and methods Review of prospective database at Tata Memorial Hospital from January 2010 to December 2012 identified 343 patients diagnosed and treated for gastric cancer. Of these, 75 underwent curative resections with D2 lymphadenectomy for proximal third gastric adenocarcinoma, which entailed proximal gastrectomy in 43 and total gastrectomy in 32 patients, depending on the epicenter of the primary and its relation with the mid-body of the stomach. Morbidity, lymph node yield, resection margins, patterns of recurrence, and survival were compared between these two groups. Results 41/75 tumors were pT3 (23 cases [53.4 %] in the PG and 18 cases [56.3 %] in the TG group). Thirty-six patients [83.7 %] in PG and 29 patients [90.6 %] in TG group received neoadjuvant chemotherapy (NACT). There were no significant differences with regard to median blood loss, general complication rates and length of hospitalization between the two groups. The lymph node yield was comparable between the two procedures [PG = 14; TG = 15]. Positive proximal resection margin rates were comparable between the two groups [PG = 4.7 %; TG = 9.4 %], and there was no statistical difference observed in the distal resection margin positivity rates [PG = 4.7 %; TG = 3.1 %]. Regarding the patterns of recurrence, local recurrence in PG was 4.7 % and there was no local recurrence in the TG group (p = 0.08). Distant recurrence rates was dominant in TG [PG = 30.2 % versus TG = 53.1 %]. The overall 2-year survival following PG and TG was 73.8 and 49.9 %, respectively, and not statistically different (p = 0.10). Conclusions The extent of resection for proximal third gastric cancer does not influence the clinical outcome. PG and TG have similar survival rates. Both procedures can be accomplished safely. Therefore, PG should be an alternative to TG, even in locally advanced proximal gastric cancers treated by NACT, provided that the tumor size and location permit preservation of adequate remnant of stomach without compromising oncological resection margins. Future QOL studies would further lend credence to the concept of PG for proximal third gastric cancer.
Description:The study aims to compare open intersphincteric resection (OISR) with laparoscopic intersphincteric resection (LISR) in terms of short-term oncological and clinical outcomes. This is a retrospective review of a prospectively maintained database including all the patients of rectal cancer who underwent intersphincteric resection (ISR) at Tata Memorial Centre between 1st July 2013 and 30th November 2015. Short-term oncological parameters evaluated included circumferential resection margin involvement (CRM), distal resection margin involvement, and number of nodes harvested. Perioperative outcomes included blood loss, length of hospital stay and 30-day postoperative morbidity and mortality. Chi-square test was used to compare the results between the two groups. Thirty nine cases of OISR and 34 cases of LISR were included in the study. Median BMI was higher in LISR group; otherwise, the two groups were comparable in all aspects. There were no conversions in LISR group. CRM involvement was seen in four patients (10%) in the conventional group compared to none in the LISR group. Median hospital stay was comparable between the two groups. Laparoscopic ISR is safe and can be performed with low conversion rate in selected group of patients.
Dr. Pavan T Sugoor is an excellent Laparoscopic Surgeon. He explained my procedure in a way that I could understand. I felt comfortable and well taken care of throughout. Highly recommend!
Dr. Pavan T Sugoor is a skilled Laparoscopic Surgeon. He performed my surgery with precision and care. The recovery was smooth and I am grateful for his expertise.
I had a great experience with Dr. Pavan T Sugoor as my Laparoscopic Surgeon. He was attentive to my concerns and the procedure went smoothly. I am pleased with the results.
Dr. Pavan T Sugoor is a compassionate Laparoscopic Surgeon. He took the time to listen to my questions and provided clear answers. The surgery was successful and I am thankful for his care.
I highly recommend Dr. Pavan T Sugoor as a Laparoscopic Surgeon. He is professional, knowledgeable, and made me feel at ease before my procedure. The outcome exceeded my expectations.
Dr. Pavan T Sugoor is an exceptional Laparoscopic Surgeon. His expertise and attention to detail are commendable. I had a positive experience under his care and would trust him again.
I am grateful for Dr. Pavan T Sugoor's expertise as a Laparoscopic Surgeon. He was thorough in explaining the procedure and ensured I felt comfortable throughout. The results were fantastic.
